Roche Diagnostics is the world's largest IVD company with revenues of approximately $17 billion in 2025, operating across immunoassay, clinical chemistry, molecular diagnostics, tissue diagnostics, and point-of-care testing. Roche's cobas series — encompassing the cobas 8000 and cobas infinity digital health platform — is the installed base leader in high-volume core laboratories globally. The NAVIFY digital pathology platform delivers AI-powered tissue analysis. Roche's partnerships with pharmaceutical companies for companion diagnostics have created a structurally growing revenue stream as precision oncology drug approvals accelerate. The company holds a leading position in hospital systems, reference laboratories, and blood screening globally.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Strategic Directions — cobas Platform Expansion, Digital Pathology, and CDx Growth Through 2030
• Financial Performance — Revenue, Revenue by Segment, Revenue by Geography, EBITDA, Margins, and R&D 2023-2025
• SWOT Analysis — Competitive Advantages, Structural Vulnerabilities, Opportunities, and Risks
• Technological Know-How — cobas, NAVIFY, Companion Diagnostics, and IP Portfolio
• Latest Products and Services — New Platform Launches, Menu Expansions, and Innovation Pipeline
• M&A — Acquisitions, Divestitures, and Partnerships 2023-2025
• Marketing Tactics — Reagent Rental Strategy, GPO Positioning, and Channel Approach
• Organization and Management — Leadership, Structure, and Workforce
Table of Contents
1. Executive Summary
2. Strategic Directions
3. Financial Performance
4. SWOT Analysis
5. Technological Know-How
6. Latest Products and Services
7. M&A
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Roche Diagnostics — Key Financial Metrics Summary 2023-2025
Table 2. Roche Diagnostics — Revenue by Segment 2023-2025
Table 3. Roche Diagnostics — Revenue by Geography 2023-2025
Table 4. Roche Diagnostics — R&D Investment 2023-2025
Table 5. Roche Diagnostics — SWOT Analysis
Table 6. Roche Diagnostics — Core Technology Capabilities and Key Platforms
Table 7. Roche Diagnostics — Key Analyzers and Reagent Portfolio
Table 8. Roche Diagnostics — M&A Activity Summary 2023-2025
Table 9. Roche Diagnostics — Key Management and Leadership
Table 10. Roche Diagnostics — Strategic Priorities 2025-2030
